
Michael O'Riordan
Michael O'Riordan is a senior journalist for theheart.org|Medscape Cardiology. He's been reporting on cardiovascular medicine since 2003 when he joined theheart.org. He is a member of theheart.org team that won the Online News Association Online Journalism Award in the category of Specialty Site Journalism in 2010 and the Gold Medal for Best Website from the Association of Healthcare Publication Editors Award in 2013. Michael is a graduate of Queen's University and has a master's degree in journalism from the University of British Columbia. He keeps his own heart tuned up by running regularly in his adopted hometown of Hamilton, ON and has completed multiple marathons, including Boston, Bermuda, Toronto, New York, and Big Sur. He can be contacted at or .
- Love 'Em or Leave 'Em: Debating the New Lipid GuidelinesJanuary 2014
- SYMPLICITY HTN-3: Renal Denervation Fails in Major StudyMarch 2014
- How Good Is the New ACC/AHA Risk Calculator?November 2013
- New Cholesterol Guidelines Abandon LDL TargetsNovember 2013
- Framingham Heart Study Celebrates 65 YearsOctober 2013
- Flu Vaccination Reduces AMI RiskAugust 2013
- Niacin Full Results in HPS2-THRIVE Aired at ACCMarch 2013
- Debating the Appropriate Sodium LevelsMay 2013
- Niacin (Niaspan) Adverse Events in AIM-HIGH, HPS2-THRIVEMarch 2013
- Single-Drug Polypharmacy in Cardiovascular DiseaseSeptember 2012